Human iPS cell-derived cardiac tissue (HiCT) for cardiac regenerative therapy
Presentation
Implantation of human iPS cell-derived engineered cardiac tissues including cardiomyocytes and multiple vascular lineages ameliorates cardiac dysfunction after myocardial infarction in a rat model
